Abstract P340: 30-Day Readmission Risk Assessment Among Patients Who Underwent Transcatheter Aortic Valve Replacement (TAVR), ACS NSQIP, 2015-2017

Anshul Saxena; Muni Rubens; Joseph Salami; Peter McGranaghan; Chintan Bhatt; Sankalp Das; Emir Veledar

Abstract P340: 30-Day Readmission Risk Assessment Among Patients Who Underwent Transcatheter Aortic Valve Replacement (TAVR), ACS NSQIP, 2015-2017

Anshul Saxena, Muni Rubens, Joseph Salami, Peter McGranaghan, Chintan Bhatt, Sankalp Das, Emir Veledar

Center for Advanced Analytics

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Circulation
Volume	141
State	Published - Jan 1 2020

Cite this

@article{2838053e9d384dd69ad069a21a6b905a,

title = "Abstract P340: 30-Day Readmission Risk Assessment Among Patients Who Underwent Transcatheter Aortic Valve Replacement (TAVR), ACS NSQIP, 2015-2017",

author = "Anshul Saxena and Muni Rubens and Joseph Salami and Peter McGranaghan and Chintan Bhatt and Sankalp Das and Emir Veledar",

note = "Circulation (2020) 141(Suppl 1):AP340",

year = "2020",

month = jan,

day = "1",

language = "American English",

volume = "141",

journal = "Circulation",

}

TY - JOUR

T1 - Abstract P340: 30-Day Readmission Risk Assessment Among Patients Who Underwent Transcatheter Aortic Valve Replacement (TAVR), ACS NSQIP, 2015-2017

AU - Saxena, Anshul

AU - Rubens, Muni

AU - Salami, Joseph

AU - McGranaghan, Peter

AU - Bhatt, Chintan

AU - Das, Sankalp

AU - Veledar, Emir

N1 - Circulation (2020) 141(Suppl 1):AP340

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3515

M3 - Article

VL - 141

JO - Circulation

JF - Circulation

ER -

Abstract P340: 30-Day Readmission Risk Assessment Among Patients Who Underwent Transcatheter Aortic Valve Replacement (TAVR), ACS NSQIP, 2015-2017

Other files and links

Cite this